Case study: Neuroleptic malignant syndrome without pyrexia

被引：20
作者：
Hynes, AFM
Vickar, EL
机构：
[1] UNIV MANITOBA, DEPT PSYCHIAT, WINNIPEG, MB R3E 3N4, CANADA
[2] HLTH SCI CTR, DEPT PSYCHIAT, SECT CHILD & ADOLESCENT PSYCHIAT, INPATIENT SERV, WINNIPEG, MB, CANADA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 1996年 / 35卷 / 07期
关键词：
neuroleptic malignant syndrome; neuroleptic induced catatonia; adolescent; fever;
D O I：
10.1097/00004583-199607000-00024
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
Fever is generally considered to be an essential feature of neuroleptic malignant syndrome (NMS). The authors present the case of a 12-year-old boy who had many features of NMS but did not have fever. This case emphasizes the importance of assessing the total clinical situation. It also supports the concept of neuroleptic-induced catatonia (NIC) and NMS as disorders on the same spectrum. A scoring system is offered as a guide to severity of NIC-NMS.
引用
收藏
页码：959 / 962
页数：4
相关论文
共 50 条
  • [41] A Fatal Case of Neuroleptic Malignant Syndrome in a Patient with Stiff Leg Syndrome
    Baykara, Z. Nur
    Efendi, Huesnue
    Toker, Kamil
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2008, 15 (02) : 103 - 107
  • [42] Neuroleptic Malignant Syndrome and Serotonin Syndrome in a Female Patient: A Clinicopathologic Case
    Carlos Gomez-Esteban, Juan
    Barcena, Joseba
    Forcadas, Maribel
    Somme, Johanne
    Agundez, Marta
    Tijero, Beatriz
    Zarranz, Juan J.
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (05) : 299 - 300
  • [43] Neuroleptic malignant syndrome after neuroleptic discontinuation
    Amore, M
    Zazzeri, N
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (08) : 1323 - 1334
  • [44] A Case Report of Neuroleptic Malignant Syndrome Induced by Clozapine Is Neuroleptic Malignant Syndrome Diagnostic Criteria Adequately Sensitive to Identify Diverse Features of the Syndrome?
    Ahmadkhaniha, Hamidreza
    Tayebi, Afshin
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2008, 2 (02) : 50 - 54
  • [45] NEUROLEPTIC-INDUCED CATATONIA OR A MILD FORM OF NEUROLEPTIC MALIGNANT SYNDROME
    KONTAXAKIS, VP
    VAIDAKIS, NM
    CHRISTODOULOU, GN
    VALERGAKI, HC
    NEUROPSYCHOBIOLOGY, 1990, 23 (01) : 38 - 40
  • [46] Neuroleptic malignant syndrome and serotonin syndrome
    Nisijima, Koichi
    Shioda, Katsutoshi
    Iwamura, Tatsunori
    NEUROBIOLOGY OF HYPERTHERMIA, 2007, 162 : 81 - 104
  • [47] Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: A case-control study
    Berardi, D
    Amore, M
    Keck, PE
    Troia, M
    Dell'Atti, M
    BIOLOGICAL PSYCHIATRY, 1998, 44 (08) : 748 - 754
  • [48] Case Reports of Neuroleptic Malignant Syndrome in Context of Quetiapine Use
    Detweiler, Mark B.
    Sullivan, Kelly
    Sharma, Taral R.
    Kim, Kye Y.
    Detweiler, Jonna G.
    PSYCHIATRIC QUARTERLY, 2013, 84 (04) : 523 - 541
  • [49] Neuroleptic Malignant Syndrome or a Statin Drug Reaction? A Case Report
    Cooper, Joyce M.
    Jones, Alison L.
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (06) : 348 - 349
  • [50] Neuroleptic malignant syndrome: case report of a recurrence related to olanzapine
    Hanel, RA
    Sandmann, MC
    Kranich, M
    De Bittencourt, PRM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1998, 56 (04) : 833 - 837
12345